Navigation Links
Hoya Announces Third Quarter and the First Nine Months Financial Results for FY2008
Date:2/5/2009

TOKYO, February 5 /PRNewswire-FirstCall/ -- HOYA Corporation today announced financial results for the third quarter ended December 31, 2008. Net sales were 112.7 billion yen for the quarter, representing a decrease of 23.3% from 147.0 billion yen in the third quarter of 2007, mainly due to order decrease and the drop in the product price resulting from global economic downturn in the main business fields such as the Electro-Optics and Vision Care, as well as PENTAX that was included in the scope of consolidation during the same period of the previous year.

Operating income for the third quarter fell 39.4%, to 16.6 billion yen, and net income was down 44.2%, to 12.6 billion yen. Earnings per share for the quarter were 29.13 yen compared with 52.22 yen in the third quarter of 2007.

For the first nine months ended December 31, 2008, the company posted a 7.4% increase in net sales over the same period of 2007, to 371.2 billion yen, however, operating income fell 23.2% to 59.1 billion yen, and net income was down 12.8%, to 52.9 billion yen. Earnings per share were 122.31 yen compared with 140.48 yen in the first nine months of 2007.

"Global economic downturn continues to have a negative impact on the Electro-Optics business in this quarter," said Hiroshi Hamada, chief operating officer of HOYA. "However, our medical field is little-affected; especially our endoscopic system business under Pentax brand showed double-digit growth on a local currency bases. We will accelerate structural reforms and at the same time, pursue selective investment and strategic marketing in all fields."

The full quarterly report is available in "Financial Statement" page in HOYA website Investor Relations section at: http://www.hoya.co.jp/english/

*Results are preliminary and unaudited.

*The yen amounts shown therein are rounded down to the nearest 100 million.

About Hoya Corporation

Hoya Corporation is a global technology company based in Tokyo, Japan, and the leading supplier of innovative and indispensable high-tech products and services based upon its advanced optics technologies. Hoya is active in four fields of business: The Eye Care provides eyeglasses, operates retail shops for contact lenses, and makes intraocular lenses for cataract surgery. The Life Care provides endoscopic system. Electro-Optics makes mask blanks and photomasks for the semiconductor devices and LCD panels, optical lenses for digital cameras, and glass memory disks for HDDs. The Imaging produces SLR/compact digital cameras, interchangeable lenses, lens modules and microlenses. Hoya now has over 80 subsidiaries and affiliates, and employs approximately 38,000 people worldwide.

    Contact Information:

    Akiko Maeyama / Naoji Ito
    Corporate Communications
    Hoya Group
    Tel: +81-3-3232-0065
    E-mail: HOYA-pr@mb.hoya.co.jp


'/>"/>
SOURCE Hoya Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... Alto, CA, USA (PRWEB) , ... April 26, ... ... popular seminar on FDA’s GMP expectations for phase I clinical trials comes to ... attended by various biotechnology and pharma professionals representing FDA regulated organizations such as ...
(Date:4/26/2017)... , April 26, 2017  Genisphere LLC, ... platform, has signed a collaborative and sponsored research ... Silvia Muro . The overall goal of ... pharmacodynamics of various 3DNA designs and formulations after ... targeting diseases of the vasculature as well as ...
(Date:4/25/2017)... ... 25, 2017 , ... Dr. Robert G. Schwartz, the principal ... today that acclaimed physiatrist Matthew Terzella, MD, has joined the practice as a ... Terzella completed his residency in Physical Medicine and Rehabilitation at UMDNJ-Robert Wood Johnson ...
(Date:4/21/2017)... DENVER, COLORADO (PRWEB) , ... April 21, 2017 ... ... Manufacturing. Awards recognized outstanding manufactures in 10 categories with over 30 nominees and ... Women in Manufacturing presented the new award and the event was hosted by ...
Breaking Biology Technology:
(Date:3/28/2017)... 28, 2017 The report "Video ... Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), and ... Global Forecast to 2022", published by MarketsandMarkets, the market ... is projected to reach USD 75.64 Billion by 2022, ... The base year considered for the study is 2016 ...
(Date:3/23/2017)... , March 23, 2017 The report "Gesture Recognition and ... Industry, and Geography - Global Forecast to 2022", published by MarketsandMarkets, the market ... CAGR of 29.63% between 2017 and 2022. Continue ... ... ...
(Date:3/22/2017)... Calif. , March 21, 2017 ... analytics company serving law enforcement agencies, announced today the ... as director of public safety business development. ... diversified law enforcement experience, including a focus on the ... In his most recent position, Mr. Sheridan served as ...
Breaking Biology News(10 mins):